Ditemukan 2 dokumen yang sesuai dengan query :: Simpan CSV
Faizatunnisa; Pembimbing: Al Asyary; Penguji: Dewi Susanna, R. Budi Haryanto, Nugi Nurdin, Jimmy Tiarlina
Abstrak:
Angka kejadian kasus DBD masih tinggi setiap tahunnya meskipun jumlah kasus kematiannya cenderung menurun, namun DBD menyebabkan gejala penyakit yang lebih berat dan sulit penanganannya bila telah menjadi koinfeksi bagi virus COVID-19. Penelitian ini bertujuan untuk Mengetahui sebaran kejadian kasus DBD Kota Palembang dan menganalisa kewaspadaan sebelum dan selama masa pandemi COVID-19. Metode penelitian kualitatif desktiptif dengan teknik wawancara mendalam terhadap 3 informan, serta melakukan telaah dokumen dari instansi Direktorat Pencegahan dan Pengendalian Penyakit Tular Vektor dan Zoonosis, Dinas Kesehatan Provinsi Sumatera Selatan, Dinas Kesehatan Kota Palembang, dan Puskesmas terkait. Hasil menunjukkan Kejadian DBD di Kota Palembang sebelum masa pandemi COVID-19 pada Tahun 2018 memiliki nilai IR 39,06 per 100.000 penduduk hal ini meningkat di tahun 2019 mencapai 41,91 per 100.000 penduduk, namun angka ini tidak melebihi target kejadian DBD yaitu 49 per 100.000 penduduk. Sedangkan kejadian DBD di Kota Palembang selama masa pandemi COVID-19 pada tahun 2020 mencapai 26,07 per 100.000 penduduk, angka ini tidak melebihi target kejadian DBD yaitu 49 per 100.000 penduduk. Pada tahun 2020 semua kecamatan di kota Palembang tidak ada yang melebihi target kejadian DBD, hal ini menunjukkan bahwa selama masa pandemi COVID-19 terjadinya penurunan kasus pada setiap kecamatan di Kota Palembang. Tingkat kewaspadaan pada tahun 2018-2019 dalam kategori baik sekali, sedangkan tahun 2020 dalam kategori cukup. Berdasarkan Analisa terhadap kejadian DBD kota Palembang dapat disimpulkan bahwa terjadinya penurunan kasus DBD selama masa pandemi COVID-19 dibandingkan sebelum masa pandemi COVID-19, karena pada masa pandemi COVID-19 adanya peraturan yang ketat yaitu PSBB, dan kewaspadaan petugas terhadap penyakit DBD menjadi teralihkan karena lebih mementingkan penurunan kasus COVID-19
The incidence of DHF is still high every year, although the number of cases of death tends to decrease. DHF causes more severe symptoms of the disease and is treated if it has become co-infected with the COVID-19 virus. This study aims to determine the distribution of cases of dengue fever in Palembang City and analyze vigilance before and during the COVID-19 pandemic. A descriptive qualitative research method with in-depth interview techniques with 3 informants was used, as well as reviewing documents from the Directorate for Prevention and Control of Vector Infectious Diseases and Zoonoses, South Sumatra Provincial Health Office, Palembang City Health Office, and related public health centers. The results show that the incidence of DHF in Palembang City before the COVID-19 pandemic in 2018 had an IR value of 39.06 per 100,000 population, this fact increased in 2019 reaching 41.91 per 100,000 population, but this figure did not exceed the target of DHF incidence of 49 per 100,000 population. 100,000 inhabitants. While the incidence of DHF in Palembang City during the COVID-19 pandemic in 2020 reached 26.07 per 100,000 population, this figure did not exceed the target of DHF incidence of 49 per 100,000 population. In 2020, none of the sub-districts in the city of Palembang exceeded the target for the incidence of dengue, this issue shows that during the COVID-19 pandemic there was a decrease in cases in every sub-district in the city of Palembang. The level of awareness in 2018-2019 was in the very good category, in 2020 it was in the moderate category. Based on the analysis of the incidence of dengue fever in Palembang, it can be ensured that there is a decrease in dengue cases during the COVID-19 pandemic compared to before the COVID-19 pandemic, because during the COVID-19 pandemic There were strict regulations, namely PSBB, and Officers' awareness of dengue has been diverted because they are more concerned with reducing COVID-19 cases
Read More
The incidence of DHF is still high every year, although the number of cases of death tends to decrease. DHF causes more severe symptoms of the disease and is treated if it has become co-infected with the COVID-19 virus. This study aims to determine the distribution of cases of dengue fever in Palembang City and analyze vigilance before and during the COVID-19 pandemic. A descriptive qualitative research method with in-depth interview techniques with 3 informants was used, as well as reviewing documents from the Directorate for Prevention and Control of Vector Infectious Diseases and Zoonoses, South Sumatra Provincial Health Office, Palembang City Health Office, and related public health centers. The results show that the incidence of DHF in Palembang City before the COVID-19 pandemic in 2018 had an IR value of 39.06 per 100,000 population, this fact increased in 2019 reaching 41.91 per 100,000 population, but this figure did not exceed the target of DHF incidence of 49 per 100,000 population. 100,000 inhabitants. While the incidence of DHF in Palembang City during the COVID-19 pandemic in 2020 reached 26.07 per 100,000 population, this figure did not exceed the target of DHF incidence of 49 per 100,000 population. In 2020, none of the sub-districts in the city of Palembang exceeded the target for the incidence of dengue, this issue shows that during the COVID-19 pandemic there was a decrease in cases in every sub-district in the city of Palembang. The level of awareness in 2018-2019 was in the very good category, in 2020 it was in the moderate category. Based on the analysis of the incidence of dengue fever in Palembang, it can be ensured that there is a decrease in dengue cases during the COVID-19 pandemic compared to before the COVID-19 pandemic, because during the COVID-19 pandemic There were strict regulations, namely PSBB, and Officers' awareness of dengue has been diverted because they are more concerned with reducing COVID-19 cases
T-6336
Depok : FKM-UI, 2022
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉
Nugi Nurdin; Promotor: Ratna Djuwita; Kopromotor: Mondastri Korib Sudaryo, Nurhayati A. Prihartono; Penguji: Tri Yunis Miko Miko, Ella Nurlaela Hadi, Yuwono, Bachti Alisjahbana, Soewarta Kosen
Abstrak:
Tuberculosis Multidrug resistant TB MDR adalah salah satu jenis resistensituberkulosis terhadap minimal dua obat anti tuberkulosis lini pertama, yaituIsoniazid INH dan Rifampicin R dengan atau tanpa resisten terhadap obat antituberkulosis lain. Prevalensi TB MDR di dunia menurut WHO tahun 2012 sebesar 12 dari kasus TB baru dan 20 dari kasus TB dengan pengobatan ulang. Hal ini masihmerupakan masalah kesehatan masyarakat dunia, termasuk di Indonesia. Penelitian inibertujuan untuk mengetahui besarnya pengaruh faktor puskesmas yang dapatmempengaruhi individu terhadap kejadian TB MDR, serta menggali faktor levelpuskesmas yang dapat menjelaskan kejadian TB MDR. Desain penelitian inimenggunakan kasus kontrol dengan mixed methods. Pengumpulan data dilakukandengan wawancara menggunakan kuesioner, diskusi terarah, wawancara mendalam danobservasi. Analisis data menggunakan regresi logistik multilevel. Hasil penelitianmenunjukkan bahwa ada variasi risiko antar puskesmas/ fasilitas kesehatan tingkatpertama yang dapat mempengaruhi individu terhadap kejadian TB MDR. Faktor-faktorpada level individu yaitu pendidikan, riwayat hasil pengobatan, kepatuhan menelanobat, dan pengetahuan, PMO dan level puskesmas yaitu penjaringan suspek dan kotakerat pasien TB/TB MDR, pengobatan TB sesuai ISTC berpengaruh terhadap prevalensiTB MDR di Provinsi Sumatera Selatan. Faktor kontekstual puskesmas dapatmenurunkan variasi risiko antar puskesmas terhadap kejadianTB MDR sebesar 18 Pengembangan strategi intervensi pengendalian TB MDR yang sesuai dengan kondisiProvinsi Sumatera Selatan adalah mengkolaborasikan penjaringan suspek TB/TBMDR, pengobatan TB/TB MDR sesuai ISTC dan jejaring eksternal ISTC.
Multidrug resistant tuberculosis MDR TB is one type of tuberculosis resistance to atleast two first line anti tuberculosis drugs, Isoniazid INH and Rifampicin R with orwithout resistance to other anti tuberculosis drugs. World prevalence of MDR TBaccording to WHO 2012 is 12 of new TB cases and 20 of TB cases with retreatment.This is still a public health problem of the world, including in Indonesia. Thisstudy aims to determine the magnitude of the influence of puskesmas factors that canaffect the individual to the incidence of MDR TB, as well as to explore the level factorof puskesmas that can explain the incidence of MDR TB. This research design use casecontrol with mixed methods. The data were collected through interviews usingquestionnaires, directional discussions, in depth interviews and observations. Dataanalysis using multilevel logistic regression. The results showed that there werevariations in risk among puskesmas that could affect individuals against MDR TBincidence. Factors at the individual level of education, history of treatment outcomes,medication adherence, and knowledge, PMO and Puskesmas levels are suspect and tightsquares of TB TB MDR patients, TB treatment according to ISTC has an effect on theprevalence of MDR TB in South Sumatera Province. Contraceptive factors puskesmas first level health facilities can reduce risk variation among puskesmas to the incidenceof MDR TD by 18 . Development of MDR TB control intervention strategyappropriate to South Sumatera Province condition is to collaborate on suspected TB TB MDR screening, TB TB MDR treatment according ISTC and ISTC externalnetwork.
Read More
D-378
Depok : FKM-UI, 2018
S3 - Disertasi Pusat Informasi Kesehatan Masyarakat
☉
